APO Research
Talk to an analyst

APO RESEARCH · REPORT

FABP1 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global FABP1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchFABP1 Antibody Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal FABP1 Antibody Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal FABP1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FABP1 Antibody Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal FABP1 Antibody Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global FABP1 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for FABP1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FABP1 Antibody include Thermo Fisher Scientific, Merck, United States Biological, Santa Cruz Biotechnology, Proteintech, ProSci, NSJ Bioreagents, G Biosciences and FineTest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global FABP1 Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of FABP1 Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents FABP1 Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the FABP1 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

FABP1 Antibody Segment by Company

Thermo Fisher Scientific

Merck

United States Biological

Santa Cruz Biotechnology

Proteintech

ProSci

NSJ Bioreagents

G Biosciences

FineTest

CUSABIO

Cell Signaling Technology

Boster Biological Technology

BioLegend

Aviva Systems Biology

Affinity Biosciences

Abnova

Abcam

FABP1 Antibody Segment by Type

Polyclonal

Monoclonal

FABP1 Antibody Segment by Application

Western Blot

Immunofluorescence

Immunohistochemistry

Others

FABP1 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FABP1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FABP1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FABP1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the FABP1 Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FABP1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of FABP1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of FABP1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. FABP1 Antibody Industry Trends Table 2. FABP1 Antibody Industry Drivers Table 3. FABP1 Antibody Industry Opportunities and Challenges Table 4. FABP1 Antibody Industry Restraints Table 5. Global FABP1 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global FABP1 Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global FABP1 Antibody Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global FABP1 Antibody Sales Market Share by Manufacturers Table 9. Global FABP1 Antibody Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global FABP1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global FABP1 Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global FABP1 Antibody Manufacturers, Product Type & Application Table 13. Global FABP1 Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global FABP1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polyclonal Table 17. Major Manufacturers of Monoclonal Table 18. Global FABP1 Antibody Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global FABP1 Antibody Sales by Type (2021-2026) & (Kg) Table 20. Global FABP1 Antibody Sales by Type (2027-2032) & (Kg) Table 21. Global FABP1 Antibody Sales Market Share by Type (2021-2026) Table 22. Global FABP1 Antibody Sales Market Share by Type (2027-2032) Table 23. Global FABP1 Antibody Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global FABP1 Antibody Revenue by Type (2021-2026) & (Kg) Table 25. Global FABP1 Antibody Revenue by Type (2027-2032) & (Kg) Table 26. Global FABP1 Antibody Revenue Market Share by Type (2021-2026) Table 27. Global FABP1 Antibody Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Western Blot Table 29. Major Manufacturers of Immunofluorescence Table 30. Major Manufacturers of Immunohistochemistry Table 31. Major Manufacturers of Others Table 32. Global FABP1 Antibody Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global FABP1 Antibody Sales by Application (2021-2026) & (Kg) Table 34. Global FABP1 Antibody Sales by Application (2027-2032) & (Kg) Table 35. Global FABP1 Antibody Sales Market Share by Application (2021-2026) Table 36. Global FABP1 Antibody Sales Market Share by Application (2027-2032) Table 37. Global FABP1 Antibody Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global FABP1 Antibody Revenue by Application (2021-2026) & (Kg) Table 39. Global FABP1 Antibody Revenue by Application (2027-2032) & (Kg) Table 40. Global FABP1 Antibody Revenue Market Share by Application (2021-2026) Table 41. Global FABP1 Antibody Revenue Market Share by Application (2027-2032) Table 42. Global FABP1 Antibody Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global FABP1 Antibody Sales by Region (2021-2026) & (Kg) Table 44. Global FABP1 Antibody Sales Market Share by Region (2021-2026) Table 45. Global FABP1 Antibody Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global FABP1 Antibody Sales Forecasted Market Share by Region (2027-2032) Table 47. North America FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 49. North America FABP1 Antibody Sales by Country (2027-2032) & (Kg) Table 50. Europe FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 52. Europe FABP1 Antibody Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific FABP1 Antibody Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa FABP1 Antibody Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa FABP1 Antibody Sales by Country (2027-2032) & (Kg) Table 59. Global FABP1 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global FABP1 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 61. Global FABP1 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 62. Global FABP1 Antibody Revenue Market Share by Region (2021-2026) Table 63. Global FABP1 Antibody Revenue Market Share by Region (2027-2032) Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific FABP1 Antibody Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck FABP1 Antibody Product Portfolio Table 73. Merck Recent Development Table 74. United States Biological Company Information Table 75. United States Biological Business Overview Table 76. United States Biological FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. United States Biological FABP1 Antibody Product Portfolio Table 78. United States Biological Recent Development Table 79. Santa Cruz Biotechnology Company Information Table 80. Santa Cruz Biotechnology Business Overview Table 81. Santa Cruz Biotechnology FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Santa Cruz Biotechnology FABP1 Antibody Product Portfolio Table 83. Santa Cruz Biotechnology Recent Development Table 84. Proteintech Company Information Table 85. Proteintech Business Overview Table 86. Proteintech FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Proteintech FABP1 Antibody Product Portfolio Table 88. Proteintech Recent Development Table 89. ProSci Company Information Table 90. ProSci Business Overview Table 91. ProSci FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. ProSci FABP1 Antibody Product Portfolio Table 93. ProSci Recent Development Table 94. NSJ Bioreagents Company Information Table 95. NSJ Bioreagents Business Overview Table 96. NSJ Bioreagents FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. NSJ Bioreagents FABP1 Antibody Product Portfolio Table 98. NSJ Bioreagents Recent Development Table 99. G Biosciences Company Information Table 100. G Biosciences Business Overview Table 101. G Biosciences FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. G Biosciences FABP1 Antibody Product Portfolio Table 103. G Biosciences Recent Development Table 104. FineTest Company Information Table 105. FineTest Business Overview Table 106. FineTest FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. FineTest FABP1 Antibody Product Portfolio Table 108. FineTest Recent Development Table 109. CUSABIO Company Information Table 110. CUSABIO Business Overview Table 111. CUSABIO FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. CUSABIO FABP1 Antibody Product Portfolio Table 113. CUSABIO Recent Development Table 114. Cell Signaling Technology Company Information Table 115. Cell Signaling Technology Business Overview Table 116. Cell Signaling Technology FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Cell Signaling Technology FABP1 Antibody Product Portfolio Table 118. Cell Signaling Technology Recent Development Table 119. Boster Biological Technology Company Information Table 120. Boster Biological Technology Business Overview Table 121. Boster Biological Technology FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Boster Biological Technology FABP1 Antibody Product Portfolio Table 123. Boster Biological Technology Recent Development Table 124. BioLegend Company Information Table 125. BioLegend Business Overview Table 126. BioLegend FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. BioLegend FABP1 Antibody Product Portfolio Table 128. BioLegend Recent Development Table 129. Aviva Systems Biology Company Information Table 130. Aviva Systems Biology Business Overview Table 131. Aviva Systems Biology FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Aviva Systems Biology FABP1 Antibody Product Portfolio Table 133. Aviva Systems Biology Recent Development Table 134. Affinity Biosciences Company Information Table 135. Affinity Biosciences Business Overview Table 136. Affinity Biosciences FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Affinity Biosciences FABP1 Antibody Product Portfolio Table 138. Affinity Biosciences Recent Development Table 139. Abnova Company Information Table 140. Abnova Business Overview Table 141. Abnova FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Abnova FABP1 Antibody Product Portfolio Table 143. Abnova Recent Development Table 144. Abcam Company Information Table 145. Abcam Business Overview Table 146. Abcam FABP1 Antibody Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Abcam FABP1 Antibody Product Portfolio Table 148. Abcam Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. FABP1 Antibody Distributors List Table 152. FABP1 Antibody Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. FABP1 Antibody Product Image Figure 2. Global FABP1 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FABP1 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global FABP1 Antibody Sales (2021-2032) & (Kg) Figure 5. Global FABP1 Antibody Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 FABP1 Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polyclonal Image Figure 9. Monoclonal Image Figure 10. Global FABP1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global FABP1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global FABP1 Antibody Sales Market Share by Type (2021-2032) Figure 13. Global FABP1 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global FABP1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global FABP1 Antibody Revenue Market Share by Type (2021-2032) Figure 16. Western Blot Image Figure 17. Immunofluorescence Image Figure 18. Immunohistochemistry Image Figure 19. Others Image Figure 20. Global FABP1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global FABP1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global FABP1 Antibody Sales Market Share by Application (2021-2032) Figure 23. Global FABP1 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global FABP1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global FABP1 Antibody Revenue Market Share by Application (2021-2032) Figure 26. North America FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America FABP1 Antibody Sales Market Share by Country (2021-2032) Figure 28. U.S. FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe FABP1 Antibody Sales Market Share by Country (2021-2032) Figure 33. Germany FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific FABP1 Antibody Sales Market Share by Country (2021-2032) Figure 40. China FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa FABP1 Antibody Sales Market Share by Country (2021-2032) Figure 48. Brazil FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile FABP1 Antibody Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global FABP1 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global FABP1 Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America FABP1 Antibody Revenue (2021-2032) & (US$ Million) Figure 59. North America FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe FABP1 Antibody Revenue (2021-2032) & (US$ Million) Figure 61. Europe FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific FABP1 Antibody Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa FABP1 Antibody Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. FABP1 Antibody Value Chain Figure 67. Manufacturing Cost Structure Figure 68. FABP1 Antibody Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Western Blot
  • Immunofluorescence
  • Immunohistochemistry
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • United States Biological
  • Santa Cruz Biotechnology
  • Proteintech
  • ProSci
  • NSJ Bioreagents
  • G Biosciences
  • FineTest
  • CUSABIO
  • Cell Signaling Technology
  • Boster Biological Technology
  • BioLegend
  • Aviva Systems Biology
  • Affinity Biosciences
  • Abnova
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global FABP1 Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global FABP1 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global FABP1 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global FABP1 Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global FABP1 Antibody Market Dynamics
  1. 2.1 FABP1 Antibody Industry Trends
  2. 2.2 FABP1 Antibody Industry Drivers
  3. 2.3 FABP1 Antibody Industry Opportunities and Challenges
  4. 2.4 FABP1 Antibody Industry Restraints
3 FABP1 Antibody Market by Manufacturers
  1. 3.1 Global FABP1 Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global FABP1 Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global FABP1 Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global FABP1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FABP1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global FABP1 Antibody Manufacturers, Product Type & Application
  7. 3.7 Global FABP1 Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FABP1 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FABP1 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FABP1 Antibody Tier 1, Tier 2, and Tier 3
4 FABP1 Antibody Market by Type
  1. 4.1 FABP1 Antibody Type Introduction
  2. 4.1.1 Polyclonal
  3. 4.1.2 Monoclonal
  4. 4.2 Global FABP1 Antibody Sales by Type
  5. 4.2.1 Global FABP1 Antibody Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global FABP1 Antibody Sales by Type (2021-2032)
  7. 4.2.3 Global FABP1 Antibody Sales Market Share by Type (2021-2032)
  8. 4.3 Global FABP1 Antibody Revenue by Type
  9. 4.3.1 Global FABP1 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global FABP1 Antibody Revenue by Type (2021-2032)
  11. 4.3.3 Global FABP1 Antibody Revenue Market Share by Type (2021-2032)
5 FABP1 Antibody Market by Application
  1. 5.1 FABP1 Antibody Application Introduction
  2. 5.1.1 Western Blot
  3. 5.1.2 Immunofluorescence
  4. 5.1.3 Immunohistochemistry
  5. 5.1.4 Others
  6. 5.2 Global FABP1 Antibody Sales by Application
  7. 5.2.1 Global FABP1 Antibody Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global FABP1 Antibody Sales by Application (2021-2032)
  9. 5.2.3 Global FABP1 Antibody Sales Market Share by Application (2021-2032)
  10. 5.3 Global FABP1 Antibody Revenue by Application
  11. 5.3.1 Global FABP1 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global FABP1 Antibody Revenue by Application (2021-2032)
  13. 5.3.3 Global FABP1 Antibody Revenue Market Share by Application (2021-2032)
6 Global FABP1 Antibody Sales by Region
  1. 6.1 Global FABP1 Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global FABP1 Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global FABP1 Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global FABP1 Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America FABP1 Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe FABP1 Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific FABP1 Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa FABP1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa FABP1 Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global FABP1 Antibody Revenue by Region
  1. 7.1 Global FABP1 Antibody Revenue by Region
  2. 7.1.1 Global FABP1 Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global FABP1 Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global FABP1 Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global FABP1 Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America FABP1 Antibody Revenue (2021-2032)
  8. 7.2.2 North America FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe FABP1 Antibody Revenue (2021-2032)
  11. 7.3.2 Europe FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific FABP1 Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa FABP1 Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa FABP1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific FABP1 Antibody Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck FABP1 Antibody Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 United States Biological
  14. 8.3.1 United States Biological Company Information
  15. 8.3.2 United States Biological Business Overview
  16. 8.3.3 United States Biological FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 United States Biological FABP1 Antibody Product Portfolio
  18. 8.3.5 United States Biological Recent Developments
  19. 8.4 Santa Cruz Biotechnology
  20. 8.4.1 Santa Cruz Biotechnology Company Information
  21. 8.4.2 Santa Cruz Biotechnology Business Overview
  22. 8.4.3 Santa Cruz Biotechnology FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Santa Cruz Biotechnology FABP1 Antibody Product Portfolio
  24. 8.4.5 Santa Cruz Biotechnology Recent Developments
  25. 8.5 Proteintech
  26. 8.5.1 Proteintech Company Information
  27. 8.5.2 Proteintech Business Overview
  28. 8.5.3 Proteintech FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Proteintech FABP1 Antibody Product Portfolio
  30. 8.5.5 Proteintech Recent Developments
  31. 8.6 ProSci
  32. 8.6.1 ProSci Company Information
  33. 8.6.2 ProSci Business Overview
  34. 8.6.3 ProSci FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ProSci FABP1 Antibody Product Portfolio
  36. 8.6.5 ProSci Recent Developments
  37. 8.7 NSJ Bioreagents
  38. 8.7.1 NSJ Bioreagents Company Information
  39. 8.7.2 NSJ Bioreagents Business Overview
  40. 8.7.3 NSJ Bioreagents FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NSJ Bioreagents FABP1 Antibody Product Portfolio
  42. 8.7.5 NSJ Bioreagents Recent Developments
  43. 8.8 G Biosciences
  44. 8.8.1 G Biosciences Company Information
  45. 8.8.2 G Biosciences Business Overview
  46. 8.8.3 G Biosciences FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 G Biosciences FABP1 Antibody Product Portfolio
  48. 8.8.5 G Biosciences Recent Developments
  49. 8.9 FineTest
  50. 8.9.1 FineTest Company Information
  51. 8.9.2 FineTest Business Overview
  52. 8.9.3 FineTest FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FineTest FABP1 Antibody Product Portfolio
  54. 8.9.5 FineTest Recent Developments
  55. 8.10 CUSABIO
  56. 8.10.1 CUSABIO Company Information
  57. 8.10.2 CUSABIO Business Overview
  58. 8.10.3 CUSABIO FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CUSABIO FABP1 Antibody Product Portfolio
  60. 8.10.5 CUSABIO Recent Developments
  61. 8.11 Cell Signaling Technology
  62. 8.11.1 Cell Signaling Technology Company Information
  63. 8.11.2 Cell Signaling Technology Business Overview
  64. 8.11.3 Cell Signaling Technology FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cell Signaling Technology FABP1 Antibody Product Portfolio
  66. 8.11.5 Cell Signaling Technology Recent Developments
  67. 8.12 Boster Biological Technology
  68. 8.12.1 Boster Biological Technology Company Information
  69. 8.12.2 Boster Biological Technology Business Overview
  70. 8.12.3 Boster Biological Technology FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boster Biological Technology FABP1 Antibody Product Portfolio
  72. 8.12.5 Boster Biological Technology Recent Developments
  73. 8.13 BioLegend
  74. 8.13.1 BioLegend Company Information
  75. 8.13.2 BioLegend Business Overview
  76. 8.13.3 BioLegend FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BioLegend FABP1 Antibody Product Portfolio
  78. 8.13.5 BioLegend Recent Developments
  79. 8.14 Aviva Systems Biology
  80. 8.14.1 Aviva Systems Biology Company Information
  81. 8.14.2 Aviva Systems Biology Business Overview
  82. 8.14.3 Aviva Systems Biology FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aviva Systems Biology FABP1 Antibody Product Portfolio
  84. 8.14.5 Aviva Systems Biology Recent Developments
  85. 8.15 Affinity Biosciences
  86. 8.15.1 Affinity Biosciences Company Information
  87. 8.15.2 Affinity Biosciences Business Overview
  88. 8.15.3 Affinity Biosciences FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Affinity Biosciences FABP1 Antibody Product Portfolio
  90. 8.15.5 Affinity Biosciences Recent Developments
  91. 8.16 Abnova
  92. 8.16.1 Abnova Company Information
  93. 8.16.2 Abnova Business Overview
  94. 8.16.3 Abnova FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Abnova FABP1 Antibody Product Portfolio
  96. 8.16.5 Abnova Recent Developments
  97. 8.17 Abcam
  98. 8.17.1 Abcam Company Information
  99. 8.17.2 Abcam Business Overview
  100. 8.17.3 Abcam FABP1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abcam FABP1 Antibody Product Portfolio
  102. 8.17.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 FABP1 Antibody Value Chain Analysis
  2. 9.1.1 FABP1 Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 FABP1 Antibody Production Mode & Process
  6. 9.2 FABP1 Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 FABP1 Antibody Distributors
  9. 9.2.3 FABP1 Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst